Company Overview and News

0
Genting among gaming stocks watched ahead of Japan vote on casino bill

2018-07-20 theedgemarkets
SINGAPORE (July 20): Asian gaming-related stocks including Genting Singapore may move ahead of a vote on a casino bill in the Upper House of the Japanese parliament.
2282 SCHYF WYNMF MCHVF 0200 GXYEF GXYYY GIGNY 0880 SJMHY MDEVF 1128 0027 G13 6425 MCHVY 1928 GIGNF SJMHF SCHYY UETMF WYNMY

0
Market uncertainty driving away some of Macau’s high rollers

2018-07-04 malaymail
HONG KONG, July 4 — The financial market turmoil triggered by escalating US-China trade tensions and a weaker Chinese currency is threatening a two-year recovery in the world’s biggest casino hub.
1128 0027 2282 MCHVY WYNMF MCHVF GXYEF GXYYY WYNMY

3
Hong Kong shares gain on investors’ optimism over Trump Kim summit

2018-06-11 scmp
Hong Kong stocks closed moderately higher on Monday ahead of a historic US-North Korea summit that investors hope might lead to peace on the Korean peninsula.
SWRAY GELYF SJMHY MDEVF 0175 1128 PXGYF 1928 SWRBF ALBHF 2282 SWRBY SCHYF WYNMF MCHVF GELYY 0200 0880 506186 MCHVY GLXYENT 0700 SJMHF SWRAF SCHYY WYNMY

0
Macau casino operator SJM spikes 8pc as Goldman upgrades target price ahead of hotel opening

2018-05-31 scmp
SJM Holdings, the Macau gaming operator owned by the family of casino mogul Stanley Ho, posted its biggest intra-day gain in over six years after US broker Goldman Sachs raised its target price to reflect the opening of its new flagship property, the Grand Lisboa Palace in mid-2019.
2282 SCHYF WYNMF MCHVF 0200 GXYEF GXYYY 0880 SJMHY MDEVF 1128 0027 MCHVY 1928 SJMHF SCHYY WYNMY

0
China’s stocks rise most in month ahead of joining MSCI benchmarks, growth prospects

2018-05-31 scmp
Fund managers buy US$1 billion of mainland equities through the stock connect schemes on Thursday, the most since April 18
2282 MCHVY SCHYF 1928 MCHVF SCHYY

0
UPDATE 1-Macau's Galaxy posts 36 pct rise in Q1 EBITDA, eyes overseas expansion push

2018-05-03 reuters
HONG KONG, May 3 (Reuters) - Macau casino operator Galaxy Entertainment Group posted a 36 percent rise in its first-quarter EBITDA due to resurgent demand from gamblers in the world’s biggest casino hub.
2282 SCHYF WYNMF MCHVF GXYEF GXYYY 0880 SJMHY 1128 0027 MCHVY 1928 SJMHF SCHYY WYNMY

0
Macau's Galaxy Entertainment posts 36 pct rise in Q1 EBITDA

2018-05-03 reuters
HONG KONG, May 3 (Reuters) - Macau casino operator Galaxy Entertainment Group posted a 36 percent rise in its first-quarter EBITDA due to resurgent demand from gamblers in the world’s biggest casino hub.
2282 SCHYF WYNMF MCHVF GXYEF GXYYY 0880 SJMHY 1128 0027 506186 MCHVY GLXYENT 1928 SJMHF SCHYY WYNMY

10
Moats React To Continued Global Volatility

2018-04-24 seekingalpha
The volatility and sell-off experienced across markets in February continued to some degree in March, with varying impact on moat companies. International moats, as represented by the Morningstar® Global ex-US Moat Focus IndexSM (MGEUMFUN, or "International Moat Index"), led the MSCI All Country World Index ex-USA again in March (-1.35% vs. -1.76%, respectively). The U.S.-oriented Morningstar® Wide Moat Focus IndexSM (MWMFTR, or "U.
GASNF 2282 WBC XNGSF CGASY EKTAF MCHVF WEBNF LB WBK MORN PDCO EKTAY WBC MCHVY XNGSY GASNY

42
What to look for as Q1 earnings hit around the globe

2018-04-18 themalaymailonline
Johnson & Johnson says as a result of tax reform, it plans to increase spending on research and capital investment by 15 per cent over the next four years. — Reuters picNEW YORK, April 18 — Trade, taxes and China are the main themes to watch for heading into first-quarter earnings, along with a spate of potential deals.
BUD 2282 CHLKF WPPGF TM SCHYF TYT WPPGY WYNMF MCHVF TOYOF RB 1128 0941 TGT CHL MCHVY 7203 1928 AHBIF SCHYY WYNMY

42
What to Look for as First-Quarter Earnings Hit Around the Globe - Bloomberg

2018-04-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
BUD 2282 CHLKF WPPGF TM SCHYF TYT WPPGY WYNMF MCHVF TOYOF RB 1128 0941 TGT CHL MCHVY 7203 1928 AHBIF SCHYY WYNMY

5
Macau makes moves to develop non-gaming sectors

2018-04-16 scmp
New HK$26.5 billion MGM Cotai integrated resort brings advanced exhibition and convention technologies, and Asia’s first dynamic theatre
MGM MLHK 2282 MCHVY MCHVF

5
Wynn's Pain Is Rivals' Gain With Macau Facing a Shakeup - Bloomberg

2018-03-23 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
2282 WYNN SCHYF DSECF WYNMF MCHVF GXYEF GXYYY 0880 SJMHY 1128 0027 MCHVY 1928 8601 DSEEY LVS SJMHF SCHYY GEBHF WYNMY

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...